FDA Drug Approval, N018893, SODIUM ACETATE

FDA Drug Approval, N018893, SODIUM ACETATE

Regular price $89.00 USD
Regular price Sale price $89.00 USD
Sale Sold out
NDA: 018893
Company: HOSPIRA
Drug Name: SODIUM ACETATE
Active Ingredients: SODIUM ACETATE
Strength: 200MEQ/100ML (2MEQ/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 05/04/1983
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details